Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -6.36% is 90% above its 4-year average of -61.82%, near the high end of its 4-year range (-182.55%–-1.56%).
80.11% above its 12-month average of -31.97%.
Reported quarterly return on assets; no daily interpolation. Q3 FY2026 (2026-03-31): -4.59%.
RETURN ON ASSETS (ROA)
-6.36%
RETURN ON ASSETS (ROA) AVG TTM
-31.97%
RETURN ON ASSETS (ROA) AVG 3Y
-31.64%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+80.11%
CURRENT VS 3Y AVG
+79.90%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-23.23%
median of 384 covered companies
CURRENT VS SECTOR MEDIAN
+72.62%
vs the sector median at left
Advanced Biomed Inc. Common Stock
Market Cap
$8.76M
Return on Assets (ROA)
-6.36%
TTM Avg
-31.97%
3Y Avg
-31.64%
5Y Avg
N/A
Market Cap
$8.37M
Return on Assets (ROA)
-29.10%
TTM Avg
-66.56%
3Y Avg
-142.45%
5Y Avg
-115.37%
Market Cap
$7.75M
Return on Assets (ROA)
-76.12%
TTM Avg
-177.28%
3Y Avg
-394.98%
5Y Avg
-300.85%
Market Cap
$9.79M
Return on Assets (ROA)
-73.89%
TTM Avg
-61.17%
3Y Avg
-50.83%
5Y Avg
-128.36%
Market Cap
$10.27M
Return on Assets (ROA)
-404.58%
TTM Avg
-269.82%
3Y Avg
-269.82%
5Y Avg
-269.82%
Market Cap
$7.03M
Return on Assets (ROA)
-206.32%
TTM Avg
-53.14%
3Y Avg
-33.03%
5Y Avg
-33.03%
Market Cap
$6.88M
Return on Assets (ROA)
-283.63%
TTM Avg
-124.17%
3Y Avg
-74.25%
5Y Avg
-35.74%
Market Cap
$10.74M
Return on Assets (ROA)
-185.94%
TTM Avg
-166.39%
3Y Avg
-133.67%
5Y Avg
-110.62%
Market Cap
$6.76M
Return on Assets (ROA)
-97.60%
TTM Avg
-274.34%
3Y Avg
-160.93%
5Y Avg
-165.76%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Advanced Biomed Inc. Common Stock (ADVB) | $8.76M | -6.36% | -31.97% | -31.64% | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.37M | -29.10% | -66.56% | -142.45% | -115.37% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | -76.12% | -177.28% | -394.98% | -300.85% |
| Ainos, Inc. (AIMD)vs › | $9.79M | -73.89% | -61.17% | -50.83% | -128.36% |
| Caring Brands, Inc. (CABR)vs › | $10.27M | -404.58% | -269.82% | -269.82% | -269.82% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.03M | -206.32% | -53.14% | -33.03% | -33.03% |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | -283.63% | -124.17% | -74.25% | -35.74% |
| Cerenome, Inc. (CNSY)vs › | $10.74M | -185.94% | -166.39% | -133.67% | -110.62% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | -97.60% | -274.34% | -160.93% | -165.76% |
| Aclarion, Inc. (ACON)vs › | $6.74M | -50.98% | -191.11% | -206.10% | -240.87% |
ROA
-6.4%
ROE
-7.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-06-30 | -1.56% |
| 2024-06-30 | -62.38% |
| 2023-06-30 | -2.64% |
| 2022-06-30 | -59.99% |
| 2021-06-30 | -182.55% |
